Donnelly DW, Hegarty A, Sharp L, Carsin AE, Deady S, McCluskey N, Comber H, Gavin AT. The impact of adjustment for socio-economic status on comparisons of cancer incidence between two European countries. Journal of Cancer Epidemiology, Volume 2013 (2013), Article ID 612514, 6 pages, doi: 10.1155/2013/612514
Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R, the EUROCARE Working Group Cancer prevalence estimates in Europe at the beginning of 2000. Oxford Journals, Medicine, Annals of Oncology, Volume 24, Issue 6, Pages 1660-1666, Published online April 2013, doi: 10.1093/annonc/mdt030
O’Rorke MA, Murray LJ, Cardwell CR, Cantwell MM, Black C, Gavin AT. Non-steroidal anti-inflammatory drug use and brain tumour risk: A case-control study within the Clinical Practice Research Datalink. Cancer Causes and Control, Cancer Causes Control. 2013 Nov;24(11):2027-34. doi: 10.1007/s10552-013-0279-9. Epub 2013 Aug 30.
McKinley J, Ofterdinger U, Young M, Barsby A, Gavin A. Investigating local relationships between trace elements in soils and cancer data. Spatial Statistics Vol. 5, 08.2013, p. 25-41, Ddi:10.1016/j.spasta.2013.05.001
Siesling A, Kwast A, Gavin A, Baili P and Otter R and EUROCHIP-3 Workpackage 5. Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: Results of EUROCHIP-3 Survey. Int J Cancer. 2013 Jun doi: 10.1002/ijc.27957. Epub 13 Dec 2012
Forbes LJ, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, Donnelly C, Haynes K, Hvidberg L, Lagerlung M, Lockwood G, Tishelman C, Vedested P, Vigmostad MN, Ramirez AJ, Wardle J. International Cancer Benchmarking Partnership Module 2 Working Group. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? British Journal of Cancer, 2013, 108, 292–300. doi:10.1038/bjc.2012.542
Quaife SL, Forbes LJL, Ramirez AJ, Brain KE, Donnelly C, Simon AE, Wardle J. Recognition of cancer warning signs and anticipated time to help-seeking in a population sample of adults in the UK. 2013 NCRI Cancer Conference, 3 - 6 November 2013, The BT Convention Centre Liverpool UK.
Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, Maxwell R, Nedrebø B, Pahlman L, Sjövall A, Spigelman A, Engholm, Gavin A, Gjerstorff ML, Hatcher J, Johannesen TB, Morris E, McGahan CE, Tracey E, Turner D, Richards MA, Coleman MP & The ICBP Module 1 Working Group. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol. 2013 Jun;52(5):919-32. doi: 10.3109/0284186X.2013.764008. Epub 2013 Apr 15
Walters S, Maringe C, Coleman MP, Peake MD, Butler J, Young N, Bergstrom S, Hanna L, Jakobsen E, Kolbeck K, Sundstrom S, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Johannesen TB, Linklater KM, McGahan CE, Steward J, Tracey E, Turner D, Richards MA, Rachet B and ICBP Module 1 Working Group. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study 2004-2007. Thorax. 2013 Jun;68(6):551-64. doi: 10.1136/thoraxjnl-2012-202297. Epub 2013 Feb 11.
Allemani C, Minicozzi P, Berrino F, Bastiaannet E, Gavin A, Galceran J, Ameijide A, Siesling S, Mangone L, Ardanaz E, Hedelin G, Mateos A, Micheli A, Sant M and the EUROCARE Working Group. Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer. 2013 May 15;132(10):2404-12. doi: 10.1002/ijc.27895. Epub 2012 Nov 7
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-LasotaB, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sanchez Perez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Bonet RP and the EUROCARE Working Group. Childhood cancer survival in Europe 1999—2007: results of EUROCARE-5—a population-based study. The Lancet Oncology, , Pages 35 - 47, published online December 2013, doi:10.1016/S1470-2045(13)70548-5
De Angelis R, Sant M, Coleman MP, Francisci S, Balili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino Capocacci R; The EUROCARE-5 Working Group. Increasing cancer survival in Europe in the first decade of the 21st century: results of the EUROCARE-5 Study. The Lancet Oncolcogy , pages 23 - 34, published online December 2013, doi:10.1016/S1470-2045(13)70546-1
Donnelly DW, Hegarty A, Sharp L, Carsin A-E, Deady S, McCluskey N, Comber H, Gavin A. The impact of adjustment for socioeconomic status on comparisons of cancer incidence between two European countries. Journal of Cancer Epidemiology Volume 2013 (2013), Article ID 612514, doi.org/10.1155/2013/612514
Carney P, Gavin A, O'Neill C. The role of private care in the interval between diagnosis and treatment of breast cancer in Northern Ireland: an analysis of Registry data. BJM, 3 December 2013; doi:10.1136/bmjopen-2013-004074
Agus AM, Kinnear H, O'Neill C, McDowell C, Crealey GE, Gavin A. Description and predictors of hospital costs of oesophageal cancer during the first year following diagnosis in Northern Ireland. European Journal of Cancer Care. January 2013, doi: 10.1111/ecc.12046
Anderson L, O'Rorke M, Jamison J, Wilson R, Gavin A on behalf of the HPV Working Group members. Prevalance of Human Papillomavirus in Women attending cervical screening in the UK and Ireland: New Data from Northern Ireland and a Systematic Review and Meta-Analysis. Journal of Medical Virology. February 2013, doi: 10.1002/jmv.23459. Epub 2012 Nov 14
Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, Boyages J, Christiansen P, Lee M, Wärnberg F, Allemani C, Engholm G, Fornander T, Gjerstorff ML, Johannesen TB, Lawrence G, McGahan CE, Middleton R, Steward J, Tracey E, Turner D, Richards MA, Coleman MP and The ICBP Module 1 Working Group. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. British Journal of Cancer, 28 February 2013; doi: 10.1038/bjc.2013.6
Hunter HL, Dolan OM, McMullen E, Donnelly D and Gavin A. Incidence and survival in patients with cutaneous malignant melanoma: experience in a UK population, 1984-2009. Br J Dermatol. 2013 Mar;168(3):676-8. doi: 10.1111/bjd.12046.